The percentage of coexpressing PD-1 and Tim-3 cells in tumor-infiltrating CD8+ T cells served as an important mediator, prognostic and predictive biomarker of aggressive phenotype, tumor size, risk of relapse and 36-month OS in RCC [93]. The gene discussed is HAVCR2; the disease is neoplasm.